The Board of Governors is chaired by Professor Leonard Kritharides and comprises nominees from The Sydney Local Health District, the Deans of Medical Schools and The University of Sydney, leading corporate executives, together with the Director of Cardiovascular Research of the Heart Research Institute.

The Board is responsible for the governance of the Institute. It approves and monitors budgets and scientific progress. The majority of the Board positions are available to be filled via election by the members of the incorporated company, the Heart Research Institute Ltd, to represent the corporate and scientific community.

The Board comprises:

Professor Leonard Kritharides


Len Kritharides is Head of Department and Director of Cardiology at Concord Repatriation General Hospital (CRGH) Sydney, Professor of Medicine at The University of Sydney, Head of the Atherosclerosis Research Laboratory Group at the ANZAC Research Institute and Deputy Clinical Director of the Cardiovascular Stream of the Sydney Local Health District. In 1994 Len completed a PhD in macrophage biology at the Heart Research Institute (HRI). After postdoctoral research at the HRI and in the USA, he took up an appointment as Staff Specialist in Cardiology at Concord Hospital in 1998 and became Head of Department in 2003. He was awarded a NSW Government Community Services Award for his contribution to Concord Repatriation General Hospital in 2006, the President’s Medal for contributions to the Cardiac Society of Australia and New Zealand in 2013, and Distinguished Researcher Award by the Australian Vascular Biology Society in 2014. He is currently Chair of the Cardiovascular Health and Advisory Committee of the National Heart Foundation and Chairs the Specialist Training Committee in Cardiology of the Royal Australian College of Physicians. He is Chairman of the Heart Research Institute.

Dr Teresa Anderson


Teresa Anderson is Chief Executive of the Sydney Local Health District (SLHD) and is responsible for the strategic and operational management of SLHD. SLHD has the following services and hospitals: Royal Prince Alfred Hospital, (Australia’s premier quaternary and tertiary hospital), Concord Hospital (a leading tertiary hospital), Canterbury and Balmain Hospitals, Sydney Dental Hospital, Community Health, Mental Health, Drug Health and Population Health services. Board appointments include IPAA NSW Council, Centenary Institute, Ingham Health Research Institute, Heart Research Institute, Central and Eastern Sydney PHN (primary health network), ANZAC Research Institute, Australian Institute of Health Service Management, Centre for Primary Health Care and Equity and HealthShare NSW (MoH).

Mr John Batistich


John Batistich is an Advisor to a range of technology start-ups and has more than 24 years of experience in research, marketing, digital innovation and general management with blue chip companies. Marketing communications led by John have won a Cannes Lion Award and an Australian Advertising Effectiveness Award. He has been a member of the Australian Market and Social Research Society Client Advisory Board and the Australian Research Awards judging panel. John holds a Masters in Management degree from Macquarie Graduate School of Management majoring in Human Resources, a Bachelor of Business degree from the University of Western Sydney majoring in Marketing and a Certificate in Digital Marketing from the Association for Data-driven Marketing and Advertising.

Mr Barry Brownjohn


Barry Brownjohn is an experienced banking and finance executive with skill sets including capital markets, risk management, corporate advisory and business planning. Senior executive roles have included capital markets and investment banking businesses in Asia, North America and in Australia serving as Managing Director of Bank of America. Utilising his deep industry experience and understanding of the use of technology in financial services he has served as an advisor to incumbent industry participants and new businesses seeking to bring innovative business models and enabling technologies to the market. Non-executive Director roles have included for Citigroup Pty Ltd, Dexus Property Group, Bakers Delight Holdings Pty Limited and The South Australian Financing Authority. Barry has a Bachelor degree in Accounting Finance and Systems from the University of New South Wales.

Mr Rod Halstead

LLB (Syd) (LLM) (Lon) FAICD

Rod Halstead is an alumni of the University of Sydney, where he graduated with a Bachelor of Laws and was subsequently awarded a degree of Master of Laws by the University of London. He is a Fellow of the Australian Institute of Company Directors. Rod has practised as a lawyer based in Sydney and has been a Partner in leading Australian law firms for in excess of 40 years. During this time he has practised extensively in corporate law, mergers and acquisitions, and corporate governance. Rod has served as director of public companies whose securities are listed on the Australian Securities Exchange and as Chair of private investment companies. He has held the position of Honorary Solicitor for The Heart Research Institute since its formation and was elected a Governor at the Annual General Meeting in May 2017.

Professor Shaun Jackson


Professor Shaun Jackson is an NHMRC Senior Principal Research Fellow (SPRF) and faculty member at the prestigious Scripps Research Institute in La Jolla, San Diego (CA, USA). Shaun was a co-founder of the Australian Centre for Blood Diseases in Melbourne and a founder of Kinacia, an Australian biotechnology company developing novel diagnostic and therapeutic products aimed at preventing blood clotting. He is currently Director of Cardiovascular Research at the Heart Research Institute and Charles Perkins Centre, as well as Research Director of Atherothrombosis Services within the Department of Cardiology at the Royal Prince Alfred Hospital (RPA). Shaun’s research interests are focussed in the area of atherothrombosis and cardiovascular disease. Shaun established his independent research laboratory in the Monash Department of Medicine at Box Hill Hospital (1998-2003). In 2004 he moved to the Alfred Medical Research and Education Precinct (AMREP), where he co-founded and became Research Director of the Australian Centre for Blood Diseases (ACBD).

Professor Wendy Jessup


Wendy Jessup completed her tertiary scientific training at the Universities of Manchester and Sheffield in the United Kingdom. She moved to Australia in 1989 to take up a position at the Heart Research Institute. She was promoted to leader of the Cell Biology Group in 1994, later also becoming Deputy-Director until shortly before her departure in 2002. Until the end of 2012 she was a Principal Research Fellow at the National Health and Medical Research Council (NHMRC) and a Professor and Principal Research Fellow in the Faculty of Medicine at the University of New South Wales, where she co-led the Macrophage Biology Group at the Centre for Vascular Research. She is now a Principal Research Fellow in the Atherosclerosis Laboratory at the ANZAC Research Institute.

Ms Cath Rogers


Cath Rogers has held several global finance and technology focused roles including with a successful software venture in London, Accenture strategy consulting in Sydney, ABN AMRO corporate finance in Sydney, and Credit Suisse investment banking in Sydney, New York and Latin America. Cath has also worked with the International Finance Corporation, part of the World Bank Group in Washington DC, Masdar Capital, a sovereign wealth fund in Abu Dhabi, Anchorage Capital Partners in Sydney and AirTree Ventures, a Sydney-based venture capital fund focused on digital and software investments. Cath is the co-founder of a technology venture called the Digital Receipt Exchange. In addition to the HRI, Cath is a Non-Executive Director of ASX Listed McGrath Real Estate and not-for-profit Heads Over Heels, which supports women entrepreneurs. Cath holds a Bachelor of Commerce majoring in Finance from the University of New South Wales and Master of Business Administration from INSEAD in France. She is a Chartered Financial Analyst and a Graduate of the Australian Institute of Company Directors.

Professor Stephen Simpson


Stephen Simpson is Academic Director of the Charles Perkins Centre, a University of Sydney cross-faculty initiative aimed at researching and implementing cross-disciplinary approaches to alleviating the burden of obesity, diabetes, cardiovascular disease and related conditions, and is the Executive Director of Obesity Australia. Stephen was born in Melbourne and grew up in Australia. After completing his undergraduate degree at the University of Queensland, he undertook his PhD at the University of London. Stephen spent 22 years at the University of Oxford, first in Experimental Psychology, then in the Department of Zoology and the Oxford University Museum of Natural History, before returning to Australia in 2005 as an Australian Research Council Federation Fellow, then ARC Laureate Fellow. Stephen, with close colleague David Raubenheimer, developed an integrative modelling framework for nutrition (the Geometric Framework), which was devised and tested using insects. This has since been applied to a wide range of organisms, from slime moulds to humans, and problems, from aquaculture and conservation biology to the dietary causes of human obesity and ageing. He has also revolutionised understanding of swarming in locusts, with research spanning neurochemical events within the brains of individual locusts to continental-scale mass migration. In 2007 Stephen was elected a Fellow of the Australian Academy of Science, in 2013 was elected a Fellow of the Royal Society of London as “one of the world’s foremost entomologists and nutritional biologists”, and in 2015 was made a Companion of the Order of Australia “for eminent service to biological and biomedical science.”